The Association of Christian Financial Advisers has welcomed the Government’s decision to investigate payday loans.
The Office of Fair Trading is to investigate payday lenders amid claims that they are taking advantage of people in financial difficulty and providing loans without checking that borrowers can afford to repay them.
The ACFA is calling for legislation to cap interest rates.
The group outlined its concerns in a letter to Chancellor George Osborne last December in which it expressed “increasing dismay” over the manner in which payday loan companies were allowed to trade.
The letter criticised the “unfair and unreasonable” interest rates charged by lenders.
According to the Independent, the typical APR charged by a payday lender is 4,000%.
“These rates of interest are not dissimilar to those of a back street loan shark, but dressed up with a fancy website and slick paced advertising,” the ACFA stated in its letter.
“Many consumers are now using this easy access to credit as a form of roll-over credit, month by month, thereby racking up unaffordable debt at extortionate rates of interest.”
The ACFA is calling upon the Chancellor to introduce legislation to cap interest rates for all personal lending, including unauthorised bank overdrafts.
It wants to see APR capped at a maximum percentage above base rate and interest limited to a rate similar to that imposed on credit unions – currently 12 per cent.
The ACFA has asked the Government to urgently introduce a measure to limit interest rates in the forthcoming budget.
“We’re delighted the government has announced this review of so-called Payday loans,” said Chairman Aidan Vaughan.
“There should be no place for the extortion of the desperate and vulnerable.”
http://tourism9.com/ http://vkins.com/
2012年2月24日星期五
OFT Investigates Payday Loans Sector
The consumer watchdog has launched an “extensive” investigation into the payday loans sector on concerns that some payday lenders may be taking advantage of people in financial difficulty.
As part of the review by the Office of Fair Trading (OFT), 50 of the biggest players in the industry will face spot on-site inspections.
Increasing pressure on household finances has helped fuel the rise of short-term, high-interest lenders but the OFT is concerned that some people are being given loans without the proper checks being carried out.
It will investigate whether firms target people unsuitable for credit, or roll over the loans so that the charges escalate to the point where they become unaffordable.
The OFT’s director of consumer credit David Fisher said: “We are concerned that some payday lenders are taking advantage of people in financial difficulty, in breach of the Consumer Credit Act and not meeting the standards set out in our guidance on irresponsible lending. This is unacceptable.
“We will work with the trade bodies to drive up standards but will also not hesitate to take enforcement action, including revoking firms’ licences to operate where necessary.”
The regulator has already written to several financial trade bodies about concerns over payday lenders’ advertising standards after assessing 50 websites.
The Consumer Finance Association (CFA), which was one of the trade organisations contacted and represents several large payday lenders, said the OFT’s approach was “absolutely right”.
“We have to identify areas of mal-practice and stamp it out. We know that there are payday lenders around who are less than transparent in their advertising and do not carry out the right levels of financial checks, in fact some of them brag about that, but they are not and will never be members of the CFA,” chief executive John Lamidey said.
“Research shows that payday loans have a valuable role to play in today’s society and meet a real need for consumers who like the short term, limited nature of the loan and want to avoid borrowing larger amounts over long periods of time.
“So the OFT’s review, by clamping down on poor quality payday lenders, will be good for consumers and good for our industry.”
The Consumer Affairs Minister Norman Lamb has also welcomed the review.
http://tourism9.com/ http://vkins.com/
As part of the review by the Office of Fair Trading (OFT), 50 of the biggest players in the industry will face spot on-site inspections.
Increasing pressure on household finances has helped fuel the rise of short-term, high-interest lenders but the OFT is concerned that some people are being given loans without the proper checks being carried out.
It will investigate whether firms target people unsuitable for credit, or roll over the loans so that the charges escalate to the point where they become unaffordable.
The OFT’s director of consumer credit David Fisher said: “We are concerned that some payday lenders are taking advantage of people in financial difficulty, in breach of the Consumer Credit Act and not meeting the standards set out in our guidance on irresponsible lending. This is unacceptable.
“We will work with the trade bodies to drive up standards but will also not hesitate to take enforcement action, including revoking firms’ licences to operate where necessary.”
The regulator has already written to several financial trade bodies about concerns over payday lenders’ advertising standards after assessing 50 websites.
The Consumer Finance Association (CFA), which was one of the trade organisations contacted and represents several large payday lenders, said the OFT’s approach was “absolutely right”.
“We have to identify areas of mal-practice and stamp it out. We know that there are payday lenders around who are less than transparent in their advertising and do not carry out the right levels of financial checks, in fact some of them brag about that, but they are not and will never be members of the CFA,” chief executive John Lamidey said.
“Research shows that payday loans have a valuable role to play in today’s society and meet a real need for consumers who like the short term, limited nature of the loan and want to avoid borrowing larger amounts over long periods of time.
“So the OFT’s review, by clamping down on poor quality payday lenders, will be good for consumers and good for our industry.”
The Consumer Affairs Minister Norman Lamb has also welcomed the review.
http://tourism9.com/ http://vkins.com/
2012年1月20日星期五
European banks prepare for worst, hoard cash
Jan 20 (IFR) – European banks are preparing for a potential worsening of the region’s sovereign and banking crisis, with many firms stockpiling cash and cutting back on loans to new clients as they seek to protect themselves against a possible seizing-up of financial markets.
Faced with 650 billion euros of debt coming due this year – almost 40 percent of which matures before the end of March – lenders are choosing to build up a cash cushion to ensure they can cover redemptions, creating a squeeze on the wider economy in the process.
Such hoarding illustrates the nervousness of lenders even after the European Central Bank injected 489 billion euros of cash into the banking system in December. Cash deposits at the ECB have ballooned since then, reaching a record 528 billion euros this week – higher than after the Lehman Brothers collapse.
“The big concern is that things might get worse,” said Bernd Hartwig, treasury manager at Nord/LB. “Political decisions are taking too long and most banks are building up liquidity just in case something happens. They are very worried that a new crisis could be a bigger than 2008.”
System-wide hoarding is the reverse of what happened the last time central banks injected hundreds of billions of long-term money into the system. Then, banks moved quickly to put the money to work and generate returns, sparking bond and equity market rallies – and economic growth.
The US Federal Reserve almost trebled the size of its balance sheet to more than $2 trillion in the months after the collapse of Lehman Brothers, pumping cash into the banking system through programs such as the Term Auction Facility. The ECB grew its balance sheet by about a quarter in that time.
WAIT AND SEE
But this time round, many banks have taken the decision to wait. While some have paid off interbank loans – so boosting the cash reserves of creditor banks – and a handful have bought some domestic government paper, most are choosing not to commit new cash to assets or to lending.
“For many banks it’s all about survival and they have just bought more time for themselves with the ECB money,” said the treasurer of one of Europe’s largest banks. “None of the fundamentals have been addressed. People are in standby mode – you might need lots of liquidity at short notice.”
There are other factors at work, too. Banks face strict new capital and liquidity rules, and many are planning to shrink their balance sheets in order to meet those targets – not buy more. They also do not want to commit to new assets because selling out could prove difficult should conditions worsen.
“The problem is completely different from 2009,” said Elie el Hayek, global head of interest rates at HSBC. “Back then, a big proportion of the money went into assets. This time, banks cannot do that simply because they need to protect their capital and liquidity. They know any mark-to-mark losses will eat into those buffers so they don’t want to take the risk.”
PREMATURE OPTIMISM?
Recent market optimism might also be premature. Although recent sovereign bond deals have been well bid, bankers say buying in secondary markets has been weak, and that there are few signs of banks using fresh cash to buy up European government bonds.
The lack of demand in secondary markets is partly due to the stigma now attached to peripheral bonds. Investors and regulators have started to ask more questions about such exposures, with the European Banking Authority penalizing banks for holding Spanish and Italian bonds during recent stress tests. Italian 10-year bond yields have fallen slightly in recent weeks, but have not dropped below 6.3 percent since early December.
“Banks are coming under political pressure to buy in the primary market,” said Pavan Wadhwa, head of global interest rate strategy at JP Morgan. “Given the lack of demand in the secondary market for peripheral paper, we estimate the ECB would need to more than double its current pace of purchases of Italian and Spanish paper to stabilize markets at the longer end.”
On the funding side, a recent fillip in bank bond deals also masks deep underlying problems. Banks have raised more through unsecured bond issues in January than they did in the whole of the second half of 2011. But only the highest rated banks have been able to get deals done.
That leaves hundreds of other firms with debts coming due and no prospect of tapping private investors. At the ECB’s first three-year long-term refinancing operation in December, 523 banks collectively borrowed 489 billion euros. Bankers expect the February three-year LTRO to be popular too.
“The concurrent increase in deposits at the ECB is consistent with banks building up funds to replace maturing debt,” Fitch Ratings said in a report this week. “We expect the next three-year funding round in February to see a similarly high level of take-up.”
NEGATIVE CARRY
Although banks earn little by depositing cash at the ECB – a measly 0.25 percent – and so effectively lose money because they are paying a much higher rate to borrow the cash in the first place either from the central bank or privately, treasury officials and CFOs feel justified making those losses.
“Running a liquidity position is a cost,” said the treasurer at a bank facing one of the highest refinancing hurdles this year, who confirmed that the bank had tapped the ECB in December only to deposit the money right back there. “But taking cheap money from the ECB is going to increase your liquidity and placate investors and shareholders.”
High deposits at the ECB are not necessarily being made by the same banks borrowing from the central bank – although there is some anecdotal evidence of a handful doing that. Rather, high deposits are indicative of cash being hoarded on a system-wide basis.
For now, banks say they will sit on the cash until the larger problems are sorted. “Do I want new customers with high risk and low rates? I don’t think so,” said one treasurer.
If, however, confidence returns to the markets and banks become less fearful, a huge bounce in asset prices is possible. Some believe that the slow build-up of cash at the ECB creates the potential for a massive asset binge should nervousness ease and bank funding stabilize. The ECB balance sheet recently reached a record 2.7 trillion euros, the highest in its short history.
(This story will appear in the January 21 issue of the International Financing Review, a Thomson Reuters Publication. www.ifre.com )
http://tourism9.com/ http://vkins.com/
Faced with 650 billion euros of debt coming due this year – almost 40 percent of which matures before the end of March – lenders are choosing to build up a cash cushion to ensure they can cover redemptions, creating a squeeze on the wider economy in the process.
Such hoarding illustrates the nervousness of lenders even after the European Central Bank injected 489 billion euros of cash into the banking system in December. Cash deposits at the ECB have ballooned since then, reaching a record 528 billion euros this week – higher than after the Lehman Brothers collapse.
“The big concern is that things might get worse,” said Bernd Hartwig, treasury manager at Nord/LB. “Political decisions are taking too long and most banks are building up liquidity just in case something happens. They are very worried that a new crisis could be a bigger than 2008.”
System-wide hoarding is the reverse of what happened the last time central banks injected hundreds of billions of long-term money into the system. Then, banks moved quickly to put the money to work and generate returns, sparking bond and equity market rallies – and economic growth.
The US Federal Reserve almost trebled the size of its balance sheet to more than $2 trillion in the months after the collapse of Lehman Brothers, pumping cash into the banking system through programs such as the Term Auction Facility. The ECB grew its balance sheet by about a quarter in that time.
WAIT AND SEE
But this time round, many banks have taken the decision to wait. While some have paid off interbank loans – so boosting the cash reserves of creditor banks – and a handful have bought some domestic government paper, most are choosing not to commit new cash to assets or to lending.
“For many banks it’s all about survival and they have just bought more time for themselves with the ECB money,” said the treasurer of one of Europe’s largest banks. “None of the fundamentals have been addressed. People are in standby mode – you might need lots of liquidity at short notice.”
There are other factors at work, too. Banks face strict new capital and liquidity rules, and many are planning to shrink their balance sheets in order to meet those targets – not buy more. They also do not want to commit to new assets because selling out could prove difficult should conditions worsen.
“The problem is completely different from 2009,” said Elie el Hayek, global head of interest rates at HSBC. “Back then, a big proportion of the money went into assets. This time, banks cannot do that simply because they need to protect their capital and liquidity. They know any mark-to-mark losses will eat into those buffers so they don’t want to take the risk.”
PREMATURE OPTIMISM?
Recent market optimism might also be premature. Although recent sovereign bond deals have been well bid, bankers say buying in secondary markets has been weak, and that there are few signs of banks using fresh cash to buy up European government bonds.
The lack of demand in secondary markets is partly due to the stigma now attached to peripheral bonds. Investors and regulators have started to ask more questions about such exposures, with the European Banking Authority penalizing banks for holding Spanish and Italian bonds during recent stress tests. Italian 10-year bond yields have fallen slightly in recent weeks, but have not dropped below 6.3 percent since early December.
“Banks are coming under political pressure to buy in the primary market,” said Pavan Wadhwa, head of global interest rate strategy at JP Morgan. “Given the lack of demand in the secondary market for peripheral paper, we estimate the ECB would need to more than double its current pace of purchases of Italian and Spanish paper to stabilize markets at the longer end.”
On the funding side, a recent fillip in bank bond deals also masks deep underlying problems. Banks have raised more through unsecured bond issues in January than they did in the whole of the second half of 2011. But only the highest rated banks have been able to get deals done.
That leaves hundreds of other firms with debts coming due and no prospect of tapping private investors. At the ECB’s first three-year long-term refinancing operation in December, 523 banks collectively borrowed 489 billion euros. Bankers expect the February three-year LTRO to be popular too.
“The concurrent increase in deposits at the ECB is consistent with banks building up funds to replace maturing debt,” Fitch Ratings said in a report this week. “We expect the next three-year funding round in February to see a similarly high level of take-up.”
NEGATIVE CARRY
Although banks earn little by depositing cash at the ECB – a measly 0.25 percent – and so effectively lose money because they are paying a much higher rate to borrow the cash in the first place either from the central bank or privately, treasury officials and CFOs feel justified making those losses.
“Running a liquidity position is a cost,” said the treasurer at a bank facing one of the highest refinancing hurdles this year, who confirmed that the bank had tapped the ECB in December only to deposit the money right back there. “But taking cheap money from the ECB is going to increase your liquidity and placate investors and shareholders.”
High deposits at the ECB are not necessarily being made by the same banks borrowing from the central bank – although there is some anecdotal evidence of a handful doing that. Rather, high deposits are indicative of cash being hoarded on a system-wide basis.
For now, banks say they will sit on the cash until the larger problems are sorted. “Do I want new customers with high risk and low rates? I don’t think so,” said one treasurer.
If, however, confidence returns to the markets and banks become less fearful, a huge bounce in asset prices is possible. Some believe that the slow build-up of cash at the ECB creates the potential for a massive asset binge should nervousness ease and bank funding stabilize. The ECB balance sheet recently reached a record 2.7 trillion euros, the highest in its short history.
(This story will appear in the January 21 issue of the International Financing Review, a Thomson Reuters Publication. www.ifre.com )
http://tourism9.com/ http://vkins.com/
2012年1月16日星期一
Acta S.p.A. – Business Update and Past Transaction Update
Acta S.p.A.
(“Acta (Berlin: A6E.BE – news) “ or “the Company“)
Business Update and
Past Transaction Update
Acta S.p.A. (AIM: ACTA), the clean energy products company, is pleased to provide an update on the recent development of the business. The Company is also providing an update in relation to developments regarding a previous transaction undertaken by the Company in December 2010.
Business update
As is evidenced by recent announcements, the Company has seen continued success and commercial validation in the applications of its highly innovative hydrogen generator products and electrolyser stacks via commercial engagement with customers and partners. In addition to the previously disclosed agreements the Company has seen an increasing number of commercial enquiries and orders across its product range. The recent acceleration in product commercialisation clearly demonstrates the commercial viability of the Company‘s products and its growth prospects.
As announced on 22 September 2011, the Company has been seeking to finance the growth of its production activities through its current banking relationships as well as through the disposal of its remaining portfolio of photovoltaic consents and the collection of grant receipts and working capital receipts due on the completion of EPC photovoltaic installation contracts. Having made a careful review of the financial resources available to it from these sources, the Board has determined that the level of capital currently available will not be sufficient to finance the Company through to full profitability and cash breakeven, and has therefore decided to seek additional funds through alternative sources to finance the working capital requirements of the Company’s current commercial expansion. The level and form of this financing has not yet been fully decided but there is a likelihood that there will be a requirement to raise additional equity.
Past transaction update
The Board also wishes to provide an update in relation to a previous transaction undertaken by the Company in December 2010.
In December 2010, Acta completed the sale of ten photovoltaic authorisations at a value of €2.45 million to a group of Italian investors through Auditors Italiana S.r.l. and Ingefin S.r.l., two Italian investment companies (the “Investment Companies”). This sale was completed and paid in full in cash in December 2010. After an initial provision in the audited results for the year ended 31 December 2010, the revenue and cash proceeds of this sale were recognised in Acta’s Interim accounts to June 2011.
At the time of the sale Acta was itself planning to build, own and operate a portfolio of photovoltaic projects if it could raise the additional capital needed. In order that Acta would have access to a sufficiently large portfolio of photovoltaic consents for own development, Acta obtained a call option (the “Call Option”) under a separate agreement to repurchase the authorisations from the Investment Companies during the period up to April 2011, at Acta’s sole discretion, if it should choose to do so. Due to the subsequent upheavals in the Italian photovoltaic sector Acta was unable to finance and implement this strategy and the option was therefore allowed to lapse.
In granting the Call Option to Acta, the Investment Companies relied upon a separate agreement with Bertam S.r.l. (“Bertam”), a company controlled by Paolo Bert, Acta’s CEO and 35.3% shareholder in Acta, under which Bertam agreed to purchase any projects that were not built by the Investment Companies or repurchased by Acta under its Call Option. This agreement that Bertam entered into was in order that Bertam could itself build out the projects if Acta did not proceed to do so. This was not disclosed at the time.
Upon further review the Board has determined that the Bertam agreement, given the involvement of Bertam as a related party of the Company, and to the degree that it allowed Acta to obtain the Call Option, should have been disclosed at the time.
The Board has satisfied itself that the sale of the photovoltaic authorisations by Acta to the Investment Companies was made at the same price as that achieved by Acta on the majority of its authorisation sales during 2010, which involved projects of a much smaller size, and that the price therefore represented a fair market price. The Board is also satisfied that Acta has received substantial benefits from the sale and has not been adversely affected.
As a result of the legislative changes to the Italian photovoltaic sector introduced by the Romani decree in March 2011 and subsequent downturn in the Italian photovoltaic sector, the Investment Companies no longer intend to build the photovoltaic consents acquired and have taken legal action against Bertam to obtain payment of €2.9 million for the photovoltaic authorisations. Accordingly the financial situation of Bertam has been adversely affected by the agreement with the Investment Companies and the fall in value of Bertam’s investment portfolio which includes the Acta shares which Bertam holds. If the legal action against Bertam ultimately should prove to be successful and an alternative settlement cannot be reached, Bertam may be required to sell shares of Acta in order to settle the Investment Companies’ claim.
- ENDS-
For further information please contact:
Media (Frankfurt: 725292 – news) enquiries:
About Acta S.p.A.
Acta S.p.A. is a developer and manufacturer of a range of clean energy products. Its (Euronext: ALITS.NX – news) product line includes market-leading compact hydrogen generators (electrolysers) which produce pure, dry and compressed hydrogen in a way that is easy-to-use and completely safe, and the Company is committed to integrating its award-winning electrolysers with renewable energy sources.
Acta’s cost-competitive electrolysers are based on its proprietary, inexpensive environmental catalyst and hydrogen conversion technologies. These products help overcome the barriers to the adoption of fuel cells, most notably the lack of a local hydrogen infrastructure.
Acta’s low-cost hydrogen generators represent a unique breakthrough in electrolyser technology. They can operate using mains power or intermittent renewable energy, and produce clean, dry hydrogen already at pressure for use in fuel cell and other applications. This unique combination of features avoids the system complexity and energy cost of further cleaning, drying and compression of the hydrogen, resulting in a simple, compact, low-cost and highly efficient system that is ideally suited for energy conversion and storage applications. In such applications, which include battery replacement and renewable energy storage, low cost and high efficiency are critical to commercial viability, while hydrogen compression is essential for the energy density of the system. No other water electrolyser currently on the market offers this combination of benefits.
Acta is focusing on delivering its products to markets with high volume demand for high-value environmental solutions (transport, back-up power, energy and leisure). It is accelerating the commercialisation of its products via partnerships with original equipment manufacturers (OEMs), distributors, and agents in these sectors, and intends to drive down production costs at high volume via contract manufacturing.
Acta S.p.A. is based near Pisa, Italy, and was admitted to trading on AIM in October 2005.
www.actagroup.it http://www.actaenergy.it/
http://tourism9.com/ http://vkins.com/
(“Acta (Berlin: A6E.BE – news) “ or “the Company“)
Business Update and
Past Transaction Update
Acta S.p.A. (AIM: ACTA), the clean energy products company, is pleased to provide an update on the recent development of the business. The Company is also providing an update in relation to developments regarding a previous transaction undertaken by the Company in December 2010.
Business update
As is evidenced by recent announcements, the Company has seen continued success and commercial validation in the applications of its highly innovative hydrogen generator products and electrolyser stacks via commercial engagement with customers and partners. In addition to the previously disclosed agreements the Company has seen an increasing number of commercial enquiries and orders across its product range. The recent acceleration in product commercialisation clearly demonstrates the commercial viability of the Company‘s products and its growth prospects.
As announced on 22 September 2011, the Company has been seeking to finance the growth of its production activities through its current banking relationships as well as through the disposal of its remaining portfolio of photovoltaic consents and the collection of grant receipts and working capital receipts due on the completion of EPC photovoltaic installation contracts. Having made a careful review of the financial resources available to it from these sources, the Board has determined that the level of capital currently available will not be sufficient to finance the Company through to full profitability and cash breakeven, and has therefore decided to seek additional funds through alternative sources to finance the working capital requirements of the Company’s current commercial expansion. The level and form of this financing has not yet been fully decided but there is a likelihood that there will be a requirement to raise additional equity.
Past transaction update
The Board also wishes to provide an update in relation to a previous transaction undertaken by the Company in December 2010.
In December 2010, Acta completed the sale of ten photovoltaic authorisations at a value of €2.45 million to a group of Italian investors through Auditors Italiana S.r.l. and Ingefin S.r.l., two Italian investment companies (the “Investment Companies”). This sale was completed and paid in full in cash in December 2010. After an initial provision in the audited results for the year ended 31 December 2010, the revenue and cash proceeds of this sale were recognised in Acta’s Interim accounts to June 2011.
At the time of the sale Acta was itself planning to build, own and operate a portfolio of photovoltaic projects if it could raise the additional capital needed. In order that Acta would have access to a sufficiently large portfolio of photovoltaic consents for own development, Acta obtained a call option (the “Call Option”) under a separate agreement to repurchase the authorisations from the Investment Companies during the period up to April 2011, at Acta’s sole discretion, if it should choose to do so. Due to the subsequent upheavals in the Italian photovoltaic sector Acta was unable to finance and implement this strategy and the option was therefore allowed to lapse.
In granting the Call Option to Acta, the Investment Companies relied upon a separate agreement with Bertam S.r.l. (“Bertam”), a company controlled by Paolo Bert, Acta’s CEO and 35.3% shareholder in Acta, under which Bertam agreed to purchase any projects that were not built by the Investment Companies or repurchased by Acta under its Call Option. This agreement that Bertam entered into was in order that Bertam could itself build out the projects if Acta did not proceed to do so. This was not disclosed at the time.
Upon further review the Board has determined that the Bertam agreement, given the involvement of Bertam as a related party of the Company, and to the degree that it allowed Acta to obtain the Call Option, should have been disclosed at the time.
The Board has satisfied itself that the sale of the photovoltaic authorisations by Acta to the Investment Companies was made at the same price as that achieved by Acta on the majority of its authorisation sales during 2010, which involved projects of a much smaller size, and that the price therefore represented a fair market price. The Board is also satisfied that Acta has received substantial benefits from the sale and has not been adversely affected.
As a result of the legislative changes to the Italian photovoltaic sector introduced by the Romani decree in March 2011 and subsequent downturn in the Italian photovoltaic sector, the Investment Companies no longer intend to build the photovoltaic consents acquired and have taken legal action against Bertam to obtain payment of €2.9 million for the photovoltaic authorisations. Accordingly the financial situation of Bertam has been adversely affected by the agreement with the Investment Companies and the fall in value of Bertam’s investment portfolio which includes the Acta shares which Bertam holds. If the legal action against Bertam ultimately should prove to be successful and an alternative settlement cannot be reached, Bertam may be required to sell shares of Acta in order to settle the Investment Companies’ claim.
- ENDS-
For further information please contact:
| Acta S.p.A Paul Barritt, Chief Financial Officer | Tel: +39 050 644281 www.actagroup.it |
| Altium Capital (Nominated Advisor) Adrian Reed / Phil Frame | Tel: +44 845 505 4343 |
| Seymour Pierce Limited (Broker) Freddy Crossley / David Banks | Tel: +44 (0)20 7107 8000 |
Media (Frankfurt: 725292 – news) enquiries:
About Acta S.p.A.
Acta S.p.A. is a developer and manufacturer of a range of clean energy products. Its (Euronext: ALITS.NX – news) product line includes market-leading compact hydrogen generators (electrolysers) which produce pure, dry and compressed hydrogen in a way that is easy-to-use and completely safe, and the Company is committed to integrating its award-winning electrolysers with renewable energy sources.
Acta’s cost-competitive electrolysers are based on its proprietary, inexpensive environmental catalyst and hydrogen conversion technologies. These products help overcome the barriers to the adoption of fuel cells, most notably the lack of a local hydrogen infrastructure.
Acta’s low-cost hydrogen generators represent a unique breakthrough in electrolyser technology. They can operate using mains power or intermittent renewable energy, and produce clean, dry hydrogen already at pressure for use in fuel cell and other applications. This unique combination of features avoids the system complexity and energy cost of further cleaning, drying and compression of the hydrogen, resulting in a simple, compact, low-cost and highly efficient system that is ideally suited for energy conversion and storage applications. In such applications, which include battery replacement and renewable energy storage, low cost and high efficiency are critical to commercial viability, while hydrogen compression is essential for the energy density of the system. No other water electrolyser currently on the market offers this combination of benefits.
Acta is focusing on delivering its products to markets with high volume demand for high-value environmental solutions (transport, back-up power, energy and leisure). It is accelerating the commercialisation of its products via partnerships with original equipment manufacturers (OEMs), distributors, and agents in these sectors, and intends to drive down production costs at high volume via contract manufacturing.
Acta S.p.A. is based near Pisa, Italy, and was admitted to trading on AIM in October 2005.
www.actagroup.it http://www.actaenergy.it/
http://tourism9.com/ http://vkins.com/
2012年1月3日星期二
Research and Markets: Travel and Tourism in China, Key Trends and Opportunities to 2015
DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/15c238/travel_and_tourism) has announced the addition of the “Travel and Tourism in China, Key Trends and Opportunities to 2015″ report to their offering.
In terms of global inbound tourist volume, China is the world’s third-most attractive travel and tourism destination, behind the US and France. Over the review period, China hosted major international events such as the 2008 Summer Olympic Games, the Asian Games and the Shanghai Expo that resulted in increased volumes of inbound tourists. The industry has also benefited from China’s strong economic growth, which resulted in generally higher levels of disposable income and increased expenditure on leisure and business tourism.
Over the forecast period, the Chinese Government is planning to invest a total of CNY7.3 trillion in an attempt to upgrade the country’s transportation infrastructure. This infrastructure investment is also expected to drive growth in the Chinese tourism industry. Over the forecast period, BRICdata expects China’s total tourist volume to record a CAGR of 9.25%, increasing from a total of 2,429.3 million in 2011 to a total of 3,461.4 million in 2015.
About This Report:
The report titled “Travel and Tourism in China, Key Trends and Opportunities to 2015″ provides top-level market analysis, information and insights, including:
This report provides an extensive analysis of the travel and tourism market in China. The information provided will allow you to:
http://tourism9.com/
In terms of global inbound tourist volume, China is the world’s third-most attractive travel and tourism destination, behind the US and France. Over the review period, China hosted major international events such as the 2008 Summer Olympic Games, the Asian Games and the Shanghai Expo that resulted in increased volumes of inbound tourists. The industry has also benefited from China’s strong economic growth, which resulted in generally higher levels of disposable income and increased expenditure on leisure and business tourism.
Over the forecast period, the Chinese Government is planning to invest a total of CNY7.3 trillion in an attempt to upgrade the country’s transportation infrastructure. This infrastructure investment is also expected to drive growth in the Chinese tourism industry. Over the forecast period, BRICdata expects China’s total tourist volume to record a CAGR of 9.25%, increasing from a total of 2,429.3 million in 2011 to a total of 3,461.4 million in 2015.
About This Report:
The report titled “Travel and Tourism in China, Key Trends and Opportunities to 2015″ provides top-level market analysis, information and insights, including:
- Historic and forecast market sizes covering the entire Chinese travel industry
- Detailed analysis of tourist spending patterns in China
- Descriptions and market outlooks for various sectors in the Chinese tourist industry, such as transportation, accommodation and travel intermediaries
- Detailed market classification across each sector with analysis using similar metrics
- Profiles of top travel and tourism companies in China
- China Auto Rental Inc.
- eHi Auto Services Co. Ltd
- HK CTS Hotels Co. Ltd.
- Marriott China
- China Odyssey Tours
- China Connection Tours
- WildChina
- Travel China Guide
- Royal Caribbean China
- China Railways
This report provides an extensive analysis of the travel and tourism market in China. The information provided will allow you to:
- Take strategic business decisions using top-level historic and forecast market data related to the Chinese travel and tourism industry and each sector within it
- Understand the demand and supply-side dynamics within the Chinese travel and tourism industry, along with key market trends and growth opportunities
- Assess the competitive landscape in the travel and tourism market in China, and formulate effective market-entry strategies
- Identify the growth opportunities and industry dynamics within the tourism industry’s key categories, including transportation, accommodation and travel intermediaries
http://tourism9.com/
2012年1月2日星期一
Medical Equipment Monthly Deals Analysis – M&A and Investment Trends, December 2011
NEW YORK , Dec. 29, 2011 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:
Medical Equipment Monthly Deals Analysis – M&A and Investment Trends, December 2011
http://www.reportlinker.com/p0351327/Medical-Equipment-Monthly-Deals-Analysis—MA-and-Investment-Trends-December-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply
Medical Equipment Monthly Deals Analysis – M&A and Investment Trends, December 2011
Summary
GlobalData’s “Medical Equipment Monthly Deals Analysis – M&A and Investment Trends, December 2011″ report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the medical equipment industry in Novemeber 2011. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, segments and geographies. Additionally, the report provides information on the top financial advisory firms in the medical equipment industry.
Data presented in this report is derived from GlobalData’s proprietary in-house Medical Equipment eTrack deals database and primary and secondary research.
Scope
- Analyze market trends for the medical equipment/medical devices market in the global arena
- Review of deal trends in anesthesia and respiratory devices, cardiovascular devices, dental devices, diabetes care devices, diagnostic imaging, drug delivery devices, endoscopy devices, ENT devices, healthcare IT, hospital supplies, in vitro diagnostics, nephrology and urology devices, neurology devices, opthalmic devices, patient monitoring, surgical equipment, and wound care management segments
- Analysis of M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships in the medical equipment market
- Summary of medical equipment deals globally in the last six months
- Information on the top deals that took place in the medical equipment market
- Geographies covered include – North America , Europe , Asia Pacific , South & Central America , and Middle East & Africa
- League Tables of financial advisors in M&A and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs
- Review the financial metrics, such as operating profit ratio, P/E ratio, and EV/EBITDA on mergers and acquisitions
Reasons to buy
- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of company divesting and acquiring assets and ways to raise capital in the market.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the medical equipment industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
1 Table of contents
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Medical Equipment, Global, Deal Summary 7
2.1 Medical Equipment, Global, Deals Analysis, November 2011 7
2.2 Medical Equipment, Global, Number of Deals by Type, November 2011 9
2.3 Medical Equipment, Global, Top Deals, November 2011 10
2.3.1 Becton, Dickinson Completes Public Offering Of Notes For $1.5 Billion 10
2.3.2 Zimmer Holdings Completes Public Offering Of Senior Notes For $550 Million 10
2.3.3 Bain Capital To Acquire Physio-Control From Medtronic For $487 Million 10
2.3.4 HMS Holdings To Acquire HealthDataInsights For $400 Million 11
2.3.5 JLL Partners To Acquire American Dental Partners For $398 Million 11
3 Medical Equipment, Global, Deal Summary, By Type 12
3.1 Medical Equipment, Global, Merger and Acquisition Deals, November 2011 12
3.2 Medical Equipment, Global, Equity Offering Deals, November 2011 13
3.3 Medical Equipment, Global, Debt Offering Deals, November 2011 14
3.4 Medical Equipment, Global, Private Equity and Venture Capital (PE/VC) Deals, November 2011 15
3.4.1 Medical Equipment, Global, Venture Capital Deals, by Stage of Financing, November 2011 16
3.5 Medical Equipment, Global, Top Venture Financing Firms, June 2011-November 2011 17
3.6 Medical Equipment, Global, Top VC Backed Companies, June 2011-November 2011 18
3.7 Medical Equipment, Global, Partnership Deals, November 2011 19
4 Medical Equipment, Global, Deal Summary by Market 20
4.1 Medical Equipment, Global, In Vitro Diagnostic Deals, November 2011 20
4.1.1 In Vitro Diagnostics – Deals of the Month 21
4.2 Medical Equipment, Global, Healthcare IT, Deals, November 2011 22
4.2.1 Healthcare IT – Deals of the Month 23
4.3 Medical Equipment, Global, Orthopedic Devices, Deals, November 2011 24
4.3.1 Orthopedic Devices – Deals of the Month 25
4.4 Medical Equipment, Global, Diagnostic Imaging Devices, Deals, November 2011 26
4.4.1 Diagnostic Imaging Devices – Deals of the Month 27
4.5 Medical Equipment, Global, Drug Delivery Devices, Deals, November 2011 28
4.5.1 Drug Delivery Devices – Deal of the Month 29
4.6 Medical Equipment, Global, Surgical Equipment, Deals, November 2011 30
4.6.1 Surgical Equipment – Deals of the Month 31
4.7 Medical Equipment, Global, Cardiovascular Devices, Deals, November 2011 32
4.7.1 Cardiovascular Devices – Deals of the Month 33
4.8 Medical Equipment, Global, Diabetes Care Devices, Deals, November 2011 34
4.8.1 Diabetes Care Devices – Deal of the Month 35
4.9 Medical Equipment, Global, Hospital Supplies, Deals, November 2011 36
4.9.1 Hospital Supplies – Deal of the Month 36
4.10 Medical Equipment, Global, Dental Devices, Deals, November 2011 37
4.10.1 Dental Devices – Deal of the Month 37
4.11 Medical Equipment, Global, Ophthalmic Devices, Deals, November 2011 38
4.11.1 Ophthalmic Devices – Deal of the Month 39
4.12 Medical Equipment, Global, Anesthesia and Respiratory Device Deals, November 2011 40
4.12.1 Anesthesia and Respiratory Devices – Deal of the Month 41
4.13 Medical Equipment, Global, Patient Monitoring Devices, Deals, November 2011 42
4.13.1 Patient Monitoring Devices – Deal of the Month 42
4.14 Medical Equipment, Global, Wound Care Management, Deals, November 2011 43
4.14.1 Wound Care Management – Deal of the Month 44
4.15 Medical Equipment, Global, Nephrology and Urology Devices, Deals, November 2011 45
4.15.1 Nephrology and Urology Devices – Deal of the Month 45
4.16 Medical Equipment, Global, Endoscopy Devices, Deals, November 2011 46
4.16.1 Endoscopy Devices – Deal of the Month 46
4.17 Medical Equipment, Global, ENT Devices, Deals, November 2011 47
4.17.1 ENT Devices – Deal of the Month 47
4.18 Medical Equipment, Global, Neurology Devices, Deals, November 2011 48
4.18.1 Neurology Devices – Deals of the Month 48
5 Medical Equipment, Deal Summary by Geography 49
5.1 Medical Equipment, North America Region, Deals, November 2011 49
5.1.1 North America – Deals of the Month 50
5.2 Medical Equipment, Europe Region, Deals, November 2011 51
5.2.1 Europe – Deals of the Month 52
5.3 Medical Equipment, Asia Pacific , Deals, November 2011 53
5.3.1 Asia-Pacific – Deals of the Month 54
5.4 Medical Equipment, Rest of the World, Deals, November 2011 55
5.4.1 Rest of the World – Deals of the Month 56
6 Medical Equipment, Global, Top Financial Advisors 57
6.1 Medical Equipment, Global, Top Financial Advisors, Mergers and Acquisitions, June 2011-November 2011 57
6.2 Medical Equipment, Global, Top Financial Advisors, Equity Offerings, June 2011-November 2011 58
6.3 Medical Equipment, Global, Top Financial Advisors, Debt Offerings, June 2011-November 2011 59
7 Further Information 60
7.1 Methodology 60
7.2 About GlobalData 60
7.3 Contact Us 61
7.4 Disclosure information 61
7.5 Disclaimer 61
List of Tables
Table 1: Medical Equipment, Global, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 8
Table 2: Medical Equipment, Global, Deals by Type, Deals (Number and %), November 2011 9
Table 3: Medical Equipment, Global, Top Deals, November 2011 10
Table 4: Medical Equipment, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 12
Table 5: Medical Equipment, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 13
Table 6: Medical Equipment, Global, Debt Offering, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 14
Table 7: Medical Equipment, Global, PE/VC, Deals Summary, Number of Deals and Deal Value (US$m), June 2011-November 2011 15
Table 8: Medical Equipment, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals and Deal Values (%), November 2011 16
Table 9: Medical Equipment, Global, Top Venture Financing Firms, Number of Deals and Deal Value (US$m), June 2011-November 2011 17
Table 10: Medical Equipment, Global, Top VC Backed Companies, June 2011-November 2011 18
Table 11: Medical Equipment, Global, Partnerships, Deals Summary, June 2011-November 2011 19
Table 12: Medical Equipment, Global, In vitro Diagnostics, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 20
Table 13: Medical Equipment, Global, Healthcare IT, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 22
Table 14: Medical Equipment, Global, Orthopedic Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 24
Table 15: Medical Equipment, Global, Diagnostic Imaging Devices, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 26
Table 16: Medical Equipment, Global, Drug Delivery Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 28
Table 17: Medical Equipment, Global, Surgical Equipment, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 30
Table 18: Medical Equipment, Global, Cardiovascular Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 32
Table 19: Medical Equipment, Global, Diabetes Care Devices, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 34
Table 20: Medical Equipment, Global, Hospital Supplies, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 36
Table 21: Medical Equipment, Global, Dental Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 37
Table 22: Medical Equipment, Global, Ophthalmic Devices, Deal Summary, Number of Deals and Deal Values (US$mf), June 2011-November 2011 38
Table 23: Medical Equipment, Global, Anesthesia and Respiratory Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 40
Table 24: Medical Equipment, Global, Patient Monitoring Devices, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 42
Table 25: Medical Equipment, Global, Wound Care Management, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 43
Table 26: Medical Equipment, Global, Nephrology and Urology Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 45
Table 27: Medical Equipment, Global, Endoscopy Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 46
Table 28: Medical Equipment, Global, ENT Devices, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 47
Table 29: Medical Equipment, Global, Neurology Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 48
Table 30: Medical Equipment, North America , Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 49
Table 31: Medical Equipment, Europe , Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 51
Table 32: Medical Equipment, Asia-Pacific , Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 53
Table 33: Medical Equipment, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 55
Table 34: Medical Equipment, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$m), June 2011-November 2011 57
Table 35: Medical Equipment, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$m), June 2011-November 2011 58
Table 36: Medical Equipment, Global, Top Financial Advisors, Debt Offerings, Number of Deals and Deal Values (US$m), June 2011-November 2011 59
List of Figures
Figure 1: Medical Equipment, Global, Number of Deals and Deal Values (US$m), June 2011-November 2011 7
Figure 2: Medical Equipment, Global, Number of Deals by Type (%), November 2011 9
Figure 3: Medical Equipment, Global, Mergers and Acquisitions, Number of Deals and Deal Values (US$m), June 2011-November 2011 12
Figure 4: Medical Equipment, Global, Equity Offering Deals, Number of Deals and Deal Values (US$m), June 2011-November 2011 13
Figure 5: Medical Equipment, Global, Debt Offering Deals, Number of Deals and Deal Values (US$m), June 2011-November 2011 14
Figure 6: Medical Equipment, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$m), June 2011-November 2011 15
Figure 7: Medical Equipment, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%) and Deal Values (%), November 2011 16
Figure 8: Medical Equipment, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$m), June 2011-November 2011 17
Figure 9: Medical Equipment, Global, Partnership Deals, June 2011-November 2011 19
Figure 10: Medical Equipment, Global, In vitro Diagnostics, Number of Deals and Deal Values (US$m), June 2011-November 2011 20
Figure 11: Medical Equipment, Global, Healthcare IT, Number of Deals and Deal Values (US$m), June 2011-November 2011 22
Figure 12: Medical Equipment, Global, Orthopedic Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 24
Figure 13: Medical Equipment, Global, Diagnostic Imaging Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 26
Figure 14: Medical Equipment, Global, Drug Delivery Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 28
Figure 15: Medical Equipment, Global, Surgical Equipment, Number of Deals and Deal Values (US$m), June 2011-November 2011 30
Figure 16: Medical Equipment, Global, Cardiovascular Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 32
Figure 17: Medical Equipment, Global, Diabetes Care Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 34
Figure 18: Medical Equipment, Global, Hospital Supplies, Number of Deals and Deal Values (US$m), June 2011-November 2011 36
Figure 19: Medical Equipment, Global, Dental Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 37
Figure 20: Medical Equipment, Global, Ophthalmic Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 38
Figure 21: Medical Equipment, Global, Anesthesia and Respiratory Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 40
Figure 22: Medical Equipment, Global, Patient Monitoring Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 42
Figure 23: Medical Equipment, Global, Wound Care Management, Number of Deals and Deal Values (US$m), June 2011-November 2011 43
Figure 24: Medical Equipment, Global, Nephrology and Urology, Number of Deals and Deal Values (US$m), June 2011-November 2011 45
Figure 25: Medical Equipment, North America , Number of Deals and Deal Values (US$m), June 2011-November 2011 49
Figure 26: Medical Equipment, Europe , Number of Deals and Deal Values (US$m), June 2011-November 2011 51
Figure 27: Medical Equipment, Asia Pacific , Number of Deals and Deal Values (US$m), June 2011-November 2011 53
Figure 28: Medical Equipment, Rest of the World, Number of Deals and Deal Values (US$m), June 2011-November 2011 55
Figure 29: Medical Equipment, Global, Top Financial Advisors, Mergers And Acquisitions, Number of Deals and Deal Values (US$m), June 2011-November 2011 57
Figure 30: Medical Equipment, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$m), June 2011-November 2011 58
Figure 31: Medical Equipment, Global, Top Financial Advisors, Debt Offerings, Number of Deals and Deal Values (US$m), June 2011-November 2011 59
Companies mentioned
To order this report:
Medical Equipment and Supply Industry: Medical Equipment Monthly Deals Analysis – M&A and Investment Trends, December 2011
More Market Research Report
Check our Industry Analysis and Insights
CONTACT:
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
http://tourism9.com/
Medical Equipment Monthly Deals Analysis – M&A and Investment Trends, December 2011
http://www.reportlinker.com/p0351327/Medical-Equipment-Monthly-Deals-Analysis—MA-and-Investment-Trends-December-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply
Medical Equipment Monthly Deals Analysis – M&A and Investment Trends, December 2011
Summary
GlobalData’s “Medical Equipment Monthly Deals Analysis – M&A and Investment Trends, December 2011″ report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the medical equipment industry in Novemeber 2011. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, segments and geographies. Additionally, the report provides information on the top financial advisory firms in the medical equipment industry.
Data presented in this report is derived from GlobalData’s proprietary in-house Medical Equipment eTrack deals database and primary and secondary research.
Scope
- Analyze market trends for the medical equipment/medical devices market in the global arena
- Review of deal trends in anesthesia and respiratory devices, cardiovascular devices, dental devices, diabetes care devices, diagnostic imaging, drug delivery devices, endoscopy devices, ENT devices, healthcare IT, hospital supplies, in vitro diagnostics, nephrology and urology devices, neurology devices, opthalmic devices, patient monitoring, surgical equipment, and wound care management segments
- Analysis of M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships in the medical equipment market
- Summary of medical equipment deals globally in the last six months
- Information on the top deals that took place in the medical equipment market
- Geographies covered include – North America , Europe , Asia Pacific , South & Central America , and Middle East & Africa
- League Tables of financial advisors in M&A and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs
- Review the financial metrics, such as operating profit ratio, P/E ratio, and EV/EBITDA on mergers and acquisitions
Reasons to buy
- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of company divesting and acquiring assets and ways to raise capital in the market.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the medical equipment industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
1 Table of contents
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Medical Equipment, Global, Deal Summary 7
2.1 Medical Equipment, Global, Deals Analysis, November 2011 7
2.2 Medical Equipment, Global, Number of Deals by Type, November 2011 9
2.3 Medical Equipment, Global, Top Deals, November 2011 10
2.3.1 Becton, Dickinson Completes Public Offering Of Notes For $1.5 Billion 10
2.3.2 Zimmer Holdings Completes Public Offering Of Senior Notes For $550 Million 10
2.3.3 Bain Capital To Acquire Physio-Control From Medtronic For $487 Million 10
2.3.4 HMS Holdings To Acquire HealthDataInsights For $400 Million 11
2.3.5 JLL Partners To Acquire American Dental Partners For $398 Million 11
3 Medical Equipment, Global, Deal Summary, By Type 12
3.1 Medical Equipment, Global, Merger and Acquisition Deals, November 2011 12
3.2 Medical Equipment, Global, Equity Offering Deals, November 2011 13
3.3 Medical Equipment, Global, Debt Offering Deals, November 2011 14
3.4 Medical Equipment, Global, Private Equity and Venture Capital (PE/VC) Deals, November 2011 15
3.4.1 Medical Equipment, Global, Venture Capital Deals, by Stage of Financing, November 2011 16
3.5 Medical Equipment, Global, Top Venture Financing Firms, June 2011-November 2011 17
3.6 Medical Equipment, Global, Top VC Backed Companies, June 2011-November 2011 18
3.7 Medical Equipment, Global, Partnership Deals, November 2011 19
4 Medical Equipment, Global, Deal Summary by Market 20
4.1 Medical Equipment, Global, In Vitro Diagnostic Deals, November 2011 20
4.1.1 In Vitro Diagnostics – Deals of the Month 21
4.2 Medical Equipment, Global, Healthcare IT, Deals, November 2011 22
4.2.1 Healthcare IT – Deals of the Month 23
4.3 Medical Equipment, Global, Orthopedic Devices, Deals, November 2011 24
4.3.1 Orthopedic Devices – Deals of the Month 25
4.4 Medical Equipment, Global, Diagnostic Imaging Devices, Deals, November 2011 26
4.4.1 Diagnostic Imaging Devices – Deals of the Month 27
4.5 Medical Equipment, Global, Drug Delivery Devices, Deals, November 2011 28
4.5.1 Drug Delivery Devices – Deal of the Month 29
4.6 Medical Equipment, Global, Surgical Equipment, Deals, November 2011 30
4.6.1 Surgical Equipment – Deals of the Month 31
4.7 Medical Equipment, Global, Cardiovascular Devices, Deals, November 2011 32
4.7.1 Cardiovascular Devices – Deals of the Month 33
4.8 Medical Equipment, Global, Diabetes Care Devices, Deals, November 2011 34
4.8.1 Diabetes Care Devices – Deal of the Month 35
4.9 Medical Equipment, Global, Hospital Supplies, Deals, November 2011 36
4.9.1 Hospital Supplies – Deal of the Month 36
4.10 Medical Equipment, Global, Dental Devices, Deals, November 2011 37
4.10.1 Dental Devices – Deal of the Month 37
4.11 Medical Equipment, Global, Ophthalmic Devices, Deals, November 2011 38
4.11.1 Ophthalmic Devices – Deal of the Month 39
4.12 Medical Equipment, Global, Anesthesia and Respiratory Device Deals, November 2011 40
4.12.1 Anesthesia and Respiratory Devices – Deal of the Month 41
4.13 Medical Equipment, Global, Patient Monitoring Devices, Deals, November 2011 42
4.13.1 Patient Monitoring Devices – Deal of the Month 42
4.14 Medical Equipment, Global, Wound Care Management, Deals, November 2011 43
4.14.1 Wound Care Management – Deal of the Month 44
4.15 Medical Equipment, Global, Nephrology and Urology Devices, Deals, November 2011 45
4.15.1 Nephrology and Urology Devices – Deal of the Month 45
4.16 Medical Equipment, Global, Endoscopy Devices, Deals, November 2011 46
4.16.1 Endoscopy Devices – Deal of the Month 46
4.17 Medical Equipment, Global, ENT Devices, Deals, November 2011 47
4.17.1 ENT Devices – Deal of the Month 47
4.18 Medical Equipment, Global, Neurology Devices, Deals, November 2011 48
4.18.1 Neurology Devices – Deals of the Month 48
5 Medical Equipment, Deal Summary by Geography 49
5.1 Medical Equipment, North America Region, Deals, November 2011 49
5.1.1 North America – Deals of the Month 50
5.2 Medical Equipment, Europe Region, Deals, November 2011 51
5.2.1 Europe – Deals of the Month 52
5.3 Medical Equipment, Asia Pacific , Deals, November 2011 53
5.3.1 Asia-Pacific – Deals of the Month 54
5.4 Medical Equipment, Rest of the World, Deals, November 2011 55
5.4.1 Rest of the World – Deals of the Month 56
6 Medical Equipment, Global, Top Financial Advisors 57
6.1 Medical Equipment, Global, Top Financial Advisors, Mergers and Acquisitions, June 2011-November 2011 57
6.2 Medical Equipment, Global, Top Financial Advisors, Equity Offerings, June 2011-November 2011 58
6.3 Medical Equipment, Global, Top Financial Advisors, Debt Offerings, June 2011-November 2011 59
7 Further Information 60
7.1 Methodology 60
7.2 About GlobalData 60
7.3 Contact Us 61
7.4 Disclosure information 61
7.5 Disclaimer 61
List of Tables
Table 1: Medical Equipment, Global, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 8
Table 2: Medical Equipment, Global, Deals by Type, Deals (Number and %), November 2011 9
Table 3: Medical Equipment, Global, Top Deals, November 2011 10
Table 4: Medical Equipment, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 12
Table 5: Medical Equipment, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 13
Table 6: Medical Equipment, Global, Debt Offering, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 14
Table 7: Medical Equipment, Global, PE/VC, Deals Summary, Number of Deals and Deal Value (US$m), June 2011-November 2011 15
Table 8: Medical Equipment, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals and Deal Values (%), November 2011 16
Table 9: Medical Equipment, Global, Top Venture Financing Firms, Number of Deals and Deal Value (US$m), June 2011-November 2011 17
Table 10: Medical Equipment, Global, Top VC Backed Companies, June 2011-November 2011 18
Table 11: Medical Equipment, Global, Partnerships, Deals Summary, June 2011-November 2011 19
Table 12: Medical Equipment, Global, In vitro Diagnostics, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 20
Table 13: Medical Equipment, Global, Healthcare IT, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 22
Table 14: Medical Equipment, Global, Orthopedic Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 24
Table 15: Medical Equipment, Global, Diagnostic Imaging Devices, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 26
Table 16: Medical Equipment, Global, Drug Delivery Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 28
Table 17: Medical Equipment, Global, Surgical Equipment, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 30
Table 18: Medical Equipment, Global, Cardiovascular Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 32
Table 19: Medical Equipment, Global, Diabetes Care Devices, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 34
Table 20: Medical Equipment, Global, Hospital Supplies, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 36
Table 21: Medical Equipment, Global, Dental Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 37
Table 22: Medical Equipment, Global, Ophthalmic Devices, Deal Summary, Number of Deals and Deal Values (US$mf), June 2011-November 2011 38
Table 23: Medical Equipment, Global, Anesthesia and Respiratory Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 40
Table 24: Medical Equipment, Global, Patient Monitoring Devices, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 42
Table 25: Medical Equipment, Global, Wound Care Management, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 43
Table 26: Medical Equipment, Global, Nephrology and Urology Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 45
Table 27: Medical Equipment, Global, Endoscopy Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 46
Table 28: Medical Equipment, Global, ENT Devices, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 47
Table 29: Medical Equipment, Global, Neurology Devices, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 48
Table 30: Medical Equipment, North America , Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 49
Table 31: Medical Equipment, Europe , Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 51
Table 32: Medical Equipment, Asia-Pacific , Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 53
Table 33: Medical Equipment, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 55
Table 34: Medical Equipment, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$m), June 2011-November 2011 57
Table 35: Medical Equipment, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$m), June 2011-November 2011 58
Table 36: Medical Equipment, Global, Top Financial Advisors, Debt Offerings, Number of Deals and Deal Values (US$m), June 2011-November 2011 59
List of Figures
Figure 1: Medical Equipment, Global, Number of Deals and Deal Values (US$m), June 2011-November 2011 7
Figure 2: Medical Equipment, Global, Number of Deals by Type (%), November 2011 9
Figure 3: Medical Equipment, Global, Mergers and Acquisitions, Number of Deals and Deal Values (US$m), June 2011-November 2011 12
Figure 4: Medical Equipment, Global, Equity Offering Deals, Number of Deals and Deal Values (US$m), June 2011-November 2011 13
Figure 5: Medical Equipment, Global, Debt Offering Deals, Number of Deals and Deal Values (US$m), June 2011-November 2011 14
Figure 6: Medical Equipment, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$m), June 2011-November 2011 15
Figure 7: Medical Equipment, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%) and Deal Values (%), November 2011 16
Figure 8: Medical Equipment, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$m), June 2011-November 2011 17
Figure 9: Medical Equipment, Global, Partnership Deals, June 2011-November 2011 19
Figure 10: Medical Equipment, Global, In vitro Diagnostics, Number of Deals and Deal Values (US$m), June 2011-November 2011 20
Figure 11: Medical Equipment, Global, Healthcare IT, Number of Deals and Deal Values (US$m), June 2011-November 2011 22
Figure 12: Medical Equipment, Global, Orthopedic Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 24
Figure 13: Medical Equipment, Global, Diagnostic Imaging Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 26
Figure 14: Medical Equipment, Global, Drug Delivery Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 28
Figure 15: Medical Equipment, Global, Surgical Equipment, Number of Deals and Deal Values (US$m), June 2011-November 2011 30
Figure 16: Medical Equipment, Global, Cardiovascular Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 32
Figure 17: Medical Equipment, Global, Diabetes Care Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 34
Figure 18: Medical Equipment, Global, Hospital Supplies, Number of Deals and Deal Values (US$m), June 2011-November 2011 36
Figure 19: Medical Equipment, Global, Dental Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 37
Figure 20: Medical Equipment, Global, Ophthalmic Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 38
Figure 21: Medical Equipment, Global, Anesthesia and Respiratory Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 40
Figure 22: Medical Equipment, Global, Patient Monitoring Devices, Number of Deals and Deal Values (US$m), June 2011-November 2011 42
Figure 23: Medical Equipment, Global, Wound Care Management, Number of Deals and Deal Values (US$m), June 2011-November 2011 43
Figure 24: Medical Equipment, Global, Nephrology and Urology, Number of Deals and Deal Values (US$m), June 2011-November 2011 45
Figure 25: Medical Equipment, North America , Number of Deals and Deal Values (US$m), June 2011-November 2011 49
Figure 26: Medical Equipment, Europe , Number of Deals and Deal Values (US$m), June 2011-November 2011 51
Figure 27: Medical Equipment, Asia Pacific , Number of Deals and Deal Values (US$m), June 2011-November 2011 53
Figure 28: Medical Equipment, Rest of the World, Number of Deals and Deal Values (US$m), June 2011-November 2011 55
Figure 29: Medical Equipment, Global, Top Financial Advisors, Mergers And Acquisitions, Number of Deals and Deal Values (US$m), June 2011-November 2011 57
Figure 30: Medical Equipment, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$m), June 2011-November 2011 58
Figure 31: Medical Equipment, Global, Top Financial Advisors, Debt Offerings, Number of Deals and Deal Values (US$m), June 2011-November 2011 59
Companies mentioned
To order this report:
Medical Equipment and Supply Industry: Medical Equipment Monthly Deals Analysis – M&A and Investment Trends, December 2011
More Market Research Report
Check our Industry Analysis and Insights
CONTACT:
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
http://tourism9.com/
Oil and Gas Monthly Deals Analysis – M&A and Investment Trends, December 2011
NEW YORK , Dec. 28, 2011 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue:
Oil and Gas Monthly Deals Analysis – M&A and Investment Trends, December 2011
http://www.reportlinker.com/p0351293/Oil-and-Gas-Monthly-Deals-Analysis—MA-and-Investment-Trends-December-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Oil_and_Gas_energy
Oil and Gas Monthly Deals Analysis – M&A and Investment Trends, December 2011
Summary
GlobalData’s “Oil and Gas Monthly Deals Analysis – M&A and Investment Trends, December 2011″ report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the oil and gas industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the oil and gas industry in Novmeber 2011. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, segments and geographies. Additionally, the report provides information on the top financial advisory firms in the oil and gas industry.
Data presented in this report is derived from GlobalData’s proprietary in-house Energy eTrack deals database and primary and secondary research.
Scope
- Analyze market trends for the oil and gas industry in the global arena
- Review of deal trends in upstream, midstream, downstream, and equipment & services segments
- Analysis of M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships in the oil and gas industry
- Summary of oil and gas deals globally in the last six months
- Information on the top deals that took place in the industry
- Geographies covered include – North America , Europe , Asia Pacific , South & Central America , and Middle East & Africa
- League Tables of financial advisors in M&A and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs
Reasons to buy
- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of company divesting and acquiring assets and ways to raise capital in the market.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the oil and gas industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
1 Table of contents
1 Table of contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Oil and Gas Industry, Global, Deals Summary 5
2.1 Oil and Gas Industry, Global, Deal Analysis, November 2011 5
2.2 Oil and Gas Industry, Global, Number of Deals by Type, November 2011 7
2.3 Oil and Gas Industry, Global, Top Deals, November 2011 8
2.3.1 KKR, Crestview Partners, NGP Energy Capital And ITOCHU To Acquire Samson Investment For $7.2 Billion 8
2.3.2 Petrogal Brasil to Issue New Shares To Sinopec For $4.8 Billion 9
2.3.3 Chesapeake Energy And EnerVest To Sell 25% Stake In 650,000 Net Acres Of Utica Shale Play For $2.44 Billion 9
2.3.4 Centrica To Acquire Oil And Gas Assets In Norway North Sea From Statoil Petroleum For $1.63 Billion 9
2.3.5 BG Group Announces Public Offering Of 3% Bonds Due 2018 For $1.38 Billion 10
2.4 Oil and Gas Industry, Global, Rumored Deals, November 2011 10
2.4.1 RWE To Sell Oil & Gas Assets In Egypt For Up To $3 Billion 10
2.4.2 Reliance Industries Plans Public Offering Of Bonds For $1 Billion 10
2.4.3 Marathon Oil Plans To Sell 10% Interest In Block 32 In Angola For $800 Million 10
3 Oil and Gas Industry, Global, Deals Summary, by Type 11
3.1 Oil and Gas Industry, Global, Asset Transactions, November 2011 11
3.2 Oil and Gas Industry, Global, Mergers and Acquisitions, November 2011 13
3.3 Oil and Gas Industry, Global, Equity Offerings, November 2011 15
3.4 Oil and Gas Industry, Global, Debt Offerings, November 2011 17
3.5 Oil and Gas Industry, Global, Private Equity/Venture Capital Deals, November 2011 19
3.6 Oil and Gas Industry, Global, Partnership Deals, November 2011 20
3.7 Partnership Deals in November 2011 21
4 Oil and Gas Industry, Global, Deals Summary, by Sector 22
4.1 Upstream Oil and Gas Deals, Global, November 2011 22
4.1.1 Upstream Energy – Deals of the Month 23
4.1.2 Upstream Oil and Gas, Global, Acquisitions and Asset Transaction Multiples, June 2011-November 2011 25
4.2 Midstream Oil and Gas Deals, Global, November 2011 26
4.2.1 Midstream Energy – Deals of the Month 27
4.3 Downstream Oil and Gas Deals, Global, November 2011 29
4.3.1 Downstream Energy – Deals of the Month 30
4.4 Oil and Gas Deals, Global, Equipment and Services, November 2011 31
4.4.1 Equipment and Services – Deals of the Month 32
5 Oil and Gas Industry, Deals Summary, by Geography 33
5.1 Oil and Gas Deals, North America , November 2011 33
5.1.1 North America – Deals of the Month 34
5.1.2 North America Oil and Gas, Upstream Acquisitions and Asset Transaction Multiples, June 2011-November 2011 36
5.2 Oil and Gas Deals, Europe , November 2011 37
5.2.1 Europe – Deals of the Month 38
5.3 Oil and Gas Deals, Asia-Pacific , November 2011 39
5.3.1 Asia-Pacific – Deals of the Month 40
5.4 Oil and Gas Deals, Rest of the World, November 2011 41
5.4.1 Rest of the World – Deals of the Month 42
6 Oil and Gas Industry, Global, Top Advisors 43
6.1 Oil and Gas Industry, Global, Top Financial Advisors, Mergers and Acquisitions, June 2011-November 2011 43
6.2 Oil and Gas Industry, Global, Top Financial Advisors, Equity Offerings, June 2011-November 2011 44
6.3 Oil and Gas Industry, Global, Top Financial Advisors, Debt Offerings, June 2011-November 2011 45
7 Further Information 46
7.1 Methodology 46
7.2 About GlobalData 46
7.3 Contact Us 47
7.4 Disclosure information 47
7.5 Disclaimer 47
List of Tables
Table 1: Oil and Gas Industry, Global, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 6
Table 2: Oil and Gas Industry, Global, Deals by Type, Number and %, November 2011 7
Table 3: Oil and Gas Industry, Global, Top Deals, November 2011 8
Table 4: Oil and Gas Industry, Global, Asset Transactions, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 11
Table 5: Oil and Gas Industry, Global, Top Asset Transactions, November 2011 12
Table 6: Oil and Gas Industry, Global, M&A Deals, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 14
Table 7: Oil and Gas Industry, Global, Top M&A Deals, November 2011 14
Table 8: Oil and Gas Industry, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 15
Table 9: Oil and Gas Industry, Global, Top Equity Offerings, November 2011 16
Table 10: Oil and Gas Industry, Global, Debt Offerings, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 17
Table 11: Oil and Gas Industry, Global, Top Debt Offerings, November 2011 18
Table 12: Oil and Gas Industry, Global, Private Equity and Venture Capital, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 19
Table 13: Oil and Gas Industry, Global, Partnerships, Number of Deals, June 2011-November 2011 20
Table 14: Upstream Oil and Gas, Global, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 23
Table 15: Upstream Oil and Gas, Global, Acquisitions and Asset Transaction Multiples, June 2011-November 2011 25
Table 16: Midstream Oil and Gas, Global, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 27
Table 17: Downstream Oil and Gas, Global, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 29
Table 18: Oil and Gas, Global, Equipment and Services, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 31
Table 19: Oil and Gas Industry, North America , Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 34
Table 20: North America Oil and Gas, Upstream Acquisitions and Asset Transaction Multiples, June 2011-November 2011 36
Table 21: Oil and Gas Industry, Europe , Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 38
Table 22: Oil and Gas Industry, Asia-Pacific , Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 40
Table 23: Oil and Gas Industry, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 41
Table 24: Oil and Gas Industry, Global, Top Financial Advisors, M&A, June 2011-November 2011 43
Table 25: Oil and Gas Industry, Global, Top Financial Advisors, Equity Offerings, June 2011-November 2011 44
Table 26: Oil and Gas Industry, Global, Top Financial Advisors, Debt Offerings, June 2011-November 2011 45
List of Figures
Figure 1: Oil and Gas Industry, Global, Number of Deals and Deal Values (US$m), June 2011-November 2011 5
Figure 2: Oil and Gas Industry, Global, Number of Deals by Type (%), November 2011 7
Figure 3: Oil and Gas Industry, Global, Asset Transactions, Number of Deals and Deal Values (US$m), June 2011-November 2011 11
Figure 4: Oil and Gas Industry, Global, M&A Deals, Number of Deals and Deal Values (US$m), June 2011-November 2011 13
Figure 5: Oil and Gas Industry, Global, Equity Offerings, Number of Deals and Deal Values (US$m), June 2011-November 2011 15
Figure 6: Oil and Gas Industry, Global, Debt Offerings, Number of Deals and Deal Values (US$m), June 2011-November 2011 17
Figure 7: Oil and Gas Industry, Global, Private Equity/Venture Capital, Number of Deals and Deal Values (US$m), June 2011-November 2011 19
Figure 8: Oil and Gas Industry, Global, Partnerships, Number of Deals, June 2011-November 2011 20
Figure 9: Upstream Oil and Gas, Global, Number of Deals and Deal Values (US$m), June 2011-November 2011 22
Figure 10: Upstream Oil and Gas, Global, Acquisitions and Asset Transaction Multiples, June 2011-November 2011 25
Figure 11: Midstream Oil and Gas, Global, Number of Deals and Deal Values (US$m), June 2011-November 2011 26
Figure 12: Downstream Oil and Gas, Global, Number of Deals and Deal Values (US$m), June 2011-November 2011 29
Figure 13: Oil and Gas, Global, Equipment and Services, Number of Deals and Deal Values (US$m), June 2011-November 2011 31
Figure 14: Oil and Gas Industry, North America , Number of Deals and Deal Values (US$m), June 2011-November 2011 33
Figure 15: North America Oil and Gas, Upstream Acquisitions and Asset Transaction Multiples, June 2011-November 2011 36
Figure 16: Oil and Gas Industry, Europe , Number of Deals and Deal Values (US$m), June 2011-November 2011 37
Figure 17: Oil and Gas Industry, Asia-Pacific , Number of Deals and Deal Values (US$m), June 2011-November 2011 39
Figure 18: Oil and Gas Industry, Rest of the World, Number of Deals and Deal Values (US$m), June 2011-November 2011 41
Figure 19: Oil and Gas Industry, Global, Top Financial Advisors, M&As, June 2011-November 2011 43
Figure 20: Oil and Gas Industry, Global, Top Financial Advisors, Equity Offerings, June 2011-November 2011 44
Figure 21: Oil and Gas Industry, Global, Top Financial Advisors, Debt Offerings, June 2011-November 2011 45
To order this report:
Oil and Gas energy Industry: Oil and Gas Monthly Deals Analysis – M&A and Investment Trends, December 2011
More Market Research Report
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
http://tourism9.com/
Oil and Gas Monthly Deals Analysis – M&A and Investment Trends, December 2011
http://www.reportlinker.com/p0351293/Oil-and-Gas-Monthly-Deals-Analysis—MA-and-Investment-Trends-December-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Oil_and_Gas_energy
Oil and Gas Monthly Deals Analysis – M&A and Investment Trends, December 2011
Summary
GlobalData’s “Oil and Gas Monthly Deals Analysis – M&A and Investment Trends, December 2011″ report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the oil and gas industry. The report provides detailed information on M&As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the oil and gas industry in Novmeber 2011. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, segments and geographies. Additionally, the report provides information on the top financial advisory firms in the oil and gas industry.
Data presented in this report is derived from GlobalData’s proprietary in-house Energy eTrack deals database and primary and secondary research.
Scope
- Analyze market trends for the oil and gas industry in the global arena
- Review of deal trends in upstream, midstream, downstream, and equipment & services segments
- Analysis of M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships in the oil and gas industry
- Summary of oil and gas deals globally in the last six months
- Information on the top deals that took place in the industry
- Geographies covered include – North America , Europe , Asia Pacific , South & Central America , and Middle East & Africa
- League Tables of financial advisors in M&A and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs
Reasons to buy
- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of company divesting and acquiring assets and ways to raise capital in the market.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the oil and gas industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
1 Table of contents
1 Table of contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Oil and Gas Industry, Global, Deals Summary 5
2.1 Oil and Gas Industry, Global, Deal Analysis, November 2011 5
2.2 Oil and Gas Industry, Global, Number of Deals by Type, November 2011 7
2.3 Oil and Gas Industry, Global, Top Deals, November 2011 8
2.3.1 KKR, Crestview Partners, NGP Energy Capital And ITOCHU To Acquire Samson Investment For $7.2 Billion 8
2.3.2 Petrogal Brasil to Issue New Shares To Sinopec For $4.8 Billion 9
2.3.3 Chesapeake Energy And EnerVest To Sell 25% Stake In 650,000 Net Acres Of Utica Shale Play For $2.44 Billion 9
2.3.4 Centrica To Acquire Oil And Gas Assets In Norway North Sea From Statoil Petroleum For $1.63 Billion 9
2.3.5 BG Group Announces Public Offering Of 3% Bonds Due 2018 For $1.38 Billion 10
2.4 Oil and Gas Industry, Global, Rumored Deals, November 2011 10
2.4.1 RWE To Sell Oil & Gas Assets In Egypt For Up To $3 Billion 10
2.4.2 Reliance Industries Plans Public Offering Of Bonds For $1 Billion 10
2.4.3 Marathon Oil Plans To Sell 10% Interest In Block 32 In Angola For $800 Million 10
3 Oil and Gas Industry, Global, Deals Summary, by Type 11
3.1 Oil and Gas Industry, Global, Asset Transactions, November 2011 11
3.2 Oil and Gas Industry, Global, Mergers and Acquisitions, November 2011 13
3.3 Oil and Gas Industry, Global, Equity Offerings, November 2011 15
3.4 Oil and Gas Industry, Global, Debt Offerings, November 2011 17
3.5 Oil and Gas Industry, Global, Private Equity/Venture Capital Deals, November 2011 19
3.6 Oil and Gas Industry, Global, Partnership Deals, November 2011 20
3.7 Partnership Deals in November 2011 21
4 Oil and Gas Industry, Global, Deals Summary, by Sector 22
4.1 Upstream Oil and Gas Deals, Global, November 2011 22
4.1.1 Upstream Energy – Deals of the Month 23
4.1.2 Upstream Oil and Gas, Global, Acquisitions and Asset Transaction Multiples, June 2011-November 2011 25
4.2 Midstream Oil and Gas Deals, Global, November 2011 26
4.2.1 Midstream Energy – Deals of the Month 27
4.3 Downstream Oil and Gas Deals, Global, November 2011 29
4.3.1 Downstream Energy – Deals of the Month 30
4.4 Oil and Gas Deals, Global, Equipment and Services, November 2011 31
4.4.1 Equipment and Services – Deals of the Month 32
5 Oil and Gas Industry, Deals Summary, by Geography 33
5.1 Oil and Gas Deals, North America , November 2011 33
5.1.1 North America – Deals of the Month 34
5.1.2 North America Oil and Gas, Upstream Acquisitions and Asset Transaction Multiples, June 2011-November 2011 36
5.2 Oil and Gas Deals, Europe , November 2011 37
5.2.1 Europe – Deals of the Month 38
5.3 Oil and Gas Deals, Asia-Pacific , November 2011 39
5.3.1 Asia-Pacific – Deals of the Month 40
5.4 Oil and Gas Deals, Rest of the World, November 2011 41
5.4.1 Rest of the World – Deals of the Month 42
6 Oil and Gas Industry, Global, Top Advisors 43
6.1 Oil and Gas Industry, Global, Top Financial Advisors, Mergers and Acquisitions, June 2011-November 2011 43
6.2 Oil and Gas Industry, Global, Top Financial Advisors, Equity Offerings, June 2011-November 2011 44
6.3 Oil and Gas Industry, Global, Top Financial Advisors, Debt Offerings, June 2011-November 2011 45
7 Further Information 46
7.1 Methodology 46
7.2 About GlobalData 46
7.3 Contact Us 47
7.4 Disclosure information 47
7.5 Disclaimer 47
List of Tables
Table 1: Oil and Gas Industry, Global, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 6
Table 2: Oil and Gas Industry, Global, Deals by Type, Number and %, November 2011 7
Table 3: Oil and Gas Industry, Global, Top Deals, November 2011 8
Table 4: Oil and Gas Industry, Global, Asset Transactions, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 11
Table 5: Oil and Gas Industry, Global, Top Asset Transactions, November 2011 12
Table 6: Oil and Gas Industry, Global, M&A Deals, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 14
Table 7: Oil and Gas Industry, Global, Top M&A Deals, November 2011 14
Table 8: Oil and Gas Industry, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 15
Table 9: Oil and Gas Industry, Global, Top Equity Offerings, November 2011 16
Table 10: Oil and Gas Industry, Global, Debt Offerings, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 17
Table 11: Oil and Gas Industry, Global, Top Debt Offerings, November 2011 18
Table 12: Oil and Gas Industry, Global, Private Equity and Venture Capital, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 19
Table 13: Oil and Gas Industry, Global, Partnerships, Number of Deals, June 2011-November 2011 20
Table 14: Upstream Oil and Gas, Global, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 23
Table 15: Upstream Oil and Gas, Global, Acquisitions and Asset Transaction Multiples, June 2011-November 2011 25
Table 16: Midstream Oil and Gas, Global, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 27
Table 17: Downstream Oil and Gas, Global, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 29
Table 18: Oil and Gas, Global, Equipment and Services, Deal Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 31
Table 19: Oil and Gas Industry, North America , Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 34
Table 20: North America Oil and Gas, Upstream Acquisitions and Asset Transaction Multiples, June 2011-November 2011 36
Table 21: Oil and Gas Industry, Europe , Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 38
Table 22: Oil and Gas Industry, Asia-Pacific , Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 40
Table 23: Oil and Gas Industry, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$m), June 2011-November 2011 41
Table 24: Oil and Gas Industry, Global, Top Financial Advisors, M&A, June 2011-November 2011 43
Table 25: Oil and Gas Industry, Global, Top Financial Advisors, Equity Offerings, June 2011-November 2011 44
Table 26: Oil and Gas Industry, Global, Top Financial Advisors, Debt Offerings, June 2011-November 2011 45
List of Figures
Figure 1: Oil and Gas Industry, Global, Number of Deals and Deal Values (US$m), June 2011-November 2011 5
Figure 2: Oil and Gas Industry, Global, Number of Deals by Type (%), November 2011 7
Figure 3: Oil and Gas Industry, Global, Asset Transactions, Number of Deals and Deal Values (US$m), June 2011-November 2011 11
Figure 4: Oil and Gas Industry, Global, M&A Deals, Number of Deals and Deal Values (US$m), June 2011-November 2011 13
Figure 5: Oil and Gas Industry, Global, Equity Offerings, Number of Deals and Deal Values (US$m), June 2011-November 2011 15
Figure 6: Oil and Gas Industry, Global, Debt Offerings, Number of Deals and Deal Values (US$m), June 2011-November 2011 17
Figure 7: Oil and Gas Industry, Global, Private Equity/Venture Capital, Number of Deals and Deal Values (US$m), June 2011-November 2011 19
Figure 8: Oil and Gas Industry, Global, Partnerships, Number of Deals, June 2011-November 2011 20
Figure 9: Upstream Oil and Gas, Global, Number of Deals and Deal Values (US$m), June 2011-November 2011 22
Figure 10: Upstream Oil and Gas, Global, Acquisitions and Asset Transaction Multiples, June 2011-November 2011 25
Figure 11: Midstream Oil and Gas, Global, Number of Deals and Deal Values (US$m), June 2011-November 2011 26
Figure 12: Downstream Oil and Gas, Global, Number of Deals and Deal Values (US$m), June 2011-November 2011 29
Figure 13: Oil and Gas, Global, Equipment and Services, Number of Deals and Deal Values (US$m), June 2011-November 2011 31
Figure 14: Oil and Gas Industry, North America , Number of Deals and Deal Values (US$m), June 2011-November 2011 33
Figure 15: North America Oil and Gas, Upstream Acquisitions and Asset Transaction Multiples, June 2011-November 2011 36
Figure 16: Oil and Gas Industry, Europe , Number of Deals and Deal Values (US$m), June 2011-November 2011 37
Figure 17: Oil and Gas Industry, Asia-Pacific , Number of Deals and Deal Values (US$m), June 2011-November 2011 39
Figure 18: Oil and Gas Industry, Rest of the World, Number of Deals and Deal Values (US$m), June 2011-November 2011 41
Figure 19: Oil and Gas Industry, Global, Top Financial Advisors, M&As, June 2011-November 2011 43
Figure 20: Oil and Gas Industry, Global, Top Financial Advisors, Equity Offerings, June 2011-November 2011 44
Figure 21: Oil and Gas Industry, Global, Top Financial Advisors, Debt Offerings, June 2011-November 2011 45
To order this report:
Oil and Gas energy Industry: Oil and Gas Monthly Deals Analysis – M&A and Investment Trends, December 2011
More Market Research Report
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626
http://tourism9.com/
订阅：
博文 (Atom)